Duloxetine Capsule, Delayed Release
Product Images NDC 60760-462

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 60760-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxc (Duloxetine 60760 462 30)

Duloxc (Duloxetine 60760 462 30)
This is a description of a medicine with the name Duorene DelzyedReease, Duloreine DeayedRekezse, Duorene DlaydReease Do Delyed Release. The medicine comes as capsules and each capsule contains 60mg of Dulevetne Defayed-Reease. The NDC number of the medicine is 60760-462-30 and each pack contains 30 capsules. The medicine is manufactured by Janta Pharma Limited in India and packaged by Smep's St. Mary's in Oro Valley, AZ. The Lot number of the medicine is 7727772 and the expiry date is mentioned as 2222. It should be stored at a temperature between 15°- 30° C (59°-86°F).*
FDA Label Image

Figure01 (Duloxetine Fig01)

Figure01 (Duloxetine Fig01)
The text describes a graph or chart showing the proportion of patients who experienced relapse over time during a treatment study involving a placebo and a drug called duloxetine. The x-axis measures time in days from randomization to relapse and ranges from 0 to 250, while the y-axis measures the proportion of patients and ranges from 0.0 to 1.0.*
FDA Label Image

Figure2 (Duloxetine Fig02)

Figure2 (Duloxetine Fig02)
This is a graph showing the proportion of patients who experienced relapse during treatment with placebo or Duloxetine over time. The x-axis represents the time in days from randomization to relapse and the y-axis represents the proportion of patients. There is a clear difference in the relapse rates between the two treatments, with Duloxetine showing a lower proportion of patients experiencing relapse over time.*
FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

Figure07 (Duloxetine Fig07)
This is a description of a pain medication called Duloxetine, which is taken once a day at a dose of either 60 mg or 120 mg. The text includes a graph showing the percentage improvement in pain from baseline. The word "Placebo" and some numbers are also present, but their meaning is unclear without additional context.*
FDA Label Image

Figure08 (Duloxetine Fig08)

FDA Label Image

Figure09 (Duloxetine Fig09)

Figure09 (Duloxetine Fig09)
This is a description of a medication called Duloxetine, which is used to alleviate pain. It is taken once a day in doses of either 60 or 120 mg. The remaining text appears to be a series of numbers and symbols which are not interpretable.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.